Four round table discussions around SGLT2 Inhibitors featuring: Dr Sam Seidu, Dr Clare Hambling, Professor Ana Cebrián and Professor Baruch Itzhak.
The topics covered in this online learning are:
- SGLT2 inhibitors in primary care practice
- Diabetes, renal and cardiovascular aspects
- Diabetes and cardiovascular disease
- SGLT2 inhibitors in cardio-metabolic-renal disease
To register; Book now
Who is the online learning suitable for:
All healthcare professionals working in primary care.
Who is the online learning suitable for:
All healthcare professionals working in primary care.